- Home
- PACK vs EBS Comparison
PACK vs EBS Comparison
Compare PACK & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACK
- EBS
- Stock Information
- Founded
- PACK 1972
- EBS 1998
- Country
- PACK United States
- EBS United States
- Employees
- PACK N/A
- EBS N/A
- Industry
- PACK Containers/Packaging
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- PACK Consumer Discretionary
- EBS Health Care
- Exchange
- PACK Nasdaq
- EBS Nasdaq
- Market Cap
- PACK 445.5M
- EBS 423.6M
- IPO Year
- PACK N/A
- EBS 2006
- Fundamental
- Price
- PACK $5.15
- EBS $9.15
- Analyst Decision
- PACK Buy
- EBS Strong Buy
- Analyst Count
- PACK 3
- EBS 2
- Target Price
- PACK $7.17
- EBS $13.50
- AVG Volume (30 Days)
- PACK 488.9K
- EBS 909.6K
- Earning Date
- PACK 10-30-2025
- EBS 10-29-2025
- Dividend Yield
- PACK N/A
- EBS N/A
- EPS Growth
- PACK N/A
- EBS N/A
- EPS
- PACK N/A
- EBS 2.53
- Revenue
- PACK $380,700,000.00
- EBS $851,600,000.00
- Revenue This Year
- PACK $11.38
- EBS N/A
- Revenue Next Year
- PACK $8.10
- EBS $19.24
- P/E Ratio
- PACK N/A
- EBS $3.62
- Revenue Growth
- PACK 10.38
- EBS N/A
- 52 Week Low
- PACK $2.91
- EBS $4.02
- 52 Week High
- PACK $8.70
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- PACK 47.47
- EBS 52.67
- Support Level
- PACK $4.96
- EBS $8.97
- Resistance Level
- PACK $5.79
- EBS $9.90
- Average True Range (ATR)
- PACK 0.32
- EBS 0.50
- MACD
- PACK -0.06
- EBS -0.03
- Stochastic Oscillator
- PACK 17.96
- EBS 37.15
About PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.